Pharmafile Logo
Pharmafocus logo
Advanced Search

COVID-19

Showing 15 posts of 602 posts found.

alex_azar_-_pete_marovich-getty_images

HHS Secretary Alex Azar accused of overruling FDA on COVID-19 test quality reviews

September 16, 2020
Research and Development COVID-19, FDA, US, USA

Allegations have emerged accusing US Health and Human Services Secretary Alex Azar of overruling the FDA over the review of …

News
gettyimages-1206570416

India signs deal for 100m doses of Russia’s Sputnik V COVID-19 vaccine

September 16, 2020
Manufacturing and Production, Research and Development COVID-19, India, Russia, Vaccine

Russia has signed a deal with an Indian pharma firm to test and deliver 100 million doses of its controversial …

News
800px-pfizer_finland_hq_february_13_2009

Pfizer’s coronavirus vaccine shows moderate side-effects in clinical study

September 16, 2020
Research and Development COVID-19, Pfizer, Pfizer vaccine, coronavirus vaccine

Pfizer has said that participants in a late-stage trial for its COVID-19 vaccine candidate have shown mild to moderate side …

News
lilly_building_with_american_flag_web

Lilly’s baricitinib/remdesivir combo lowers recovery time in hospitalised COVID-19 patients, according to new data

September 15, 2020
Manufacturing and Production, Research and Development COVID-19, Eli Lilly, pharma, remdesivir

Eli Lilly has unveiled promising new data from a study investigating the efficacy of baricitinib when combined with with Gilead’s …

News
shutterstock_38078521

AstraZeneca and Oxford Uni’s COVID-19 vaccine trial resumes following safety review

September 14, 2020
Research and Development, Sales and Marketing AstraZeneca, COVID-19, Oxford University, Vaccine

After sparking a wave of concern through industry and mainstream media with the news it had halted international studies investigating …

News
top_10_image_2

Top Ten most popular articles on Pharmafile.com this week

September 11, 2020
Medical Communications COVID-19, coronavirus, vaccines

The top 10 news stories this week largely cover COVID-19 vaccines, as hundreds of thousands of people in China have …

News

AstraZeneca slams brakes on COVID-19 vaccine trial over unexplained participant illness

September 9, 2020
Research and Development AstraZeneca, COVID-19, pharma

Global trials for AstraZeneca’s much-hyped COVID-19 vaccine, currently in development in partnership with the University of Oxford, have been halted …

News
800px-sanofi_frankfurt_iph

President of Sanofi France expects COVID-19 vaccine to be priced below ten Euros

September 7, 2020
Sales and Marketing COVID-19, GSK, Sanofi

The President of Sanofi France expects the coronavirus vaccine it is developing with GlaxoSmithKline to be priced under 10 Euros.  …

News
vaccination-1215279_960_720

New poll indicates most Americans will not get a COVID-19 vaccine when it’s first available

September 7, 2020
Sales and Marketing COVID, COVID-19, COVID-19 vaccine, coronavirus

Two-thirds of Americans say they will not get vaccinated against COVID-19 when a treatment first becomes available, according to a …

News
shutterstock_95714119

Meta-analysis reinforces efficacy of commercially available steroids in hospitalised COVID-19 patients

September 4, 2020
Medical Communications, Research and Development COVID-19, pharma, steroids

A new meta-analysis of seven studies worldwide investigating the benefit for commercially available steroid therapies in the treatment of COVID-19 …

News
782px-golden_hamster_front_1

Johnson & Johnson’s vaccine candidate for COVID-19 has shown efficacy in a small group of Syrian golden hamsters

September 4, 2020
Medical Communications COVID-19, J&J, JJ

Johnson & Johnson’s vaccine candidate for COVID-19 has shown efficacy in a small group of Syrian golden hamsters.

News
800px-vaccine

Sanofi halts Phase 3 trial of Kevzara as a COVID-19 treatment

September 1, 2020
Manufacturing and Production COVID-19, Sanofi, Vaccine, pharma

Sanofi is halting clinical trials treating serious COVID-19 patients with its Kevzara drug after data on its efficacy proved inconclusive.The …

News
200707-f-zc102-1004

Korea approves Celltrion’s Phase 1 trial of COVID-19 antiviral antibody treatment

August 28, 2020
Medical Communications COVID-19, antibodies, coronavirus vaccine

Celltrion Group has announced that the Korean Ministry of Food and Drug Safety has approved the company’s Investigational New Drug …

News
top_10_image_2

Top Ten most popular articles on Pharmafile.com this week

August 28, 2020
Medical Communications COVID-19, Vaccine, coronavirus vaccine, top 10

The top 10 news stories this week are focused on coronavirus vaccines and treatments, as China is set to move …

News
covid_innovations_bamc_1

Genexine’s cytokine drug effective in treating coronavirus patients, new study suggests

August 27, 2020
Research and Development COVID-19

Genexine’s recent clinical trial investigating how its cytokine therapy treats coronavirus has proven effective, according to the company. 

News
The Gateway to Local Adoption Series

Latest content

Siemens Healthineers opens 10m euro R&D centre for laboratory equipment in Ireland

February 19, 2026

Everdrone announces new board of directors to drive expansion

February 19, 2026

Regeneron announces presentations of new data on Eylea HD for retinal disease

February 18, 2026

Indegene completes acquisition of Cake Health

February 18, 2026

Gedeon Richter UK acquires rights to schizophrenia treatment Reagila from Recordati Pharmaceuticals

February 17, 2026